Skip to content
State of the Industry: Molecular Diagnostics in the Clinical Lab
*
1.
What is your title/position within the lab facility? (Select only one)
(Required.)
Pathologist/physician
Lab director
Lab manager/administrator/supervisor
Chief/asst chief medical technologist
Section head/department manager
Hospital administrator
LIS/EMR/EHR staff or manager
POCC/POCT coordinator
Compliance/QA coordinator/manager
Group practice manager/administrator
Owner/officer
Educator/department chair/faculty
Clinical chemist
Microbiologist
Hematologist
CLS
MLS-Medical laboratory scientist
MLT-Medical laboratory technician
Phlebotomist/nurse
Other (please specify)
*
2.
What type of facility best describes where you work? (Select only one)
(Required.)
Hospital/Healthcare system lab
Independent lab
Physician’s office lab
Group practice lab
Government/public health lab
Medical school/Med Tech/CLS ed program
Blood bank
PPO/HMO
Freestanding emergency center/ambulatory care center
Biomedical industrial lab
Other (please specify)
*
3.
In 2025, what has been the average number of molecular-based tests (non-COVID-19) performed by your lab daily? (Select only one)
(Required.)
0-100
101-200
201-300
301-400
400+
*
4.
How much has respiratory testing increased at your lab in 2025? (Select only one)
(Required.)
0-25 percent
26-50 percent
51-75 percent
76-100 percent
101+ percent
It has decreased
*
5.
Has your lab experienced issues with maintaining a supply of testing products due to supply chain issues? (Select only one)
(Required.)
Yes, a lack of testing supplies has impeded our testing capacity at times.
No, we have adequate testing supplies to meet testing demands.
*
6.
What testing supplies are you having trouble sourcing due to supply chain issues? (Select all that apply)
(Required.)
Blood collection tubes
Blood culture transfer devices
Controls/Reagents
Culture media
PPE
Pipettes/Pipette tips
Swabs/Consumables
Testing kits for SARS-CoV-2
Transport media
Urine testing supplies
Winged blood collection sets
Lab plastic supplies not noted above
None
Other (please specify)
*
7.
What types of molecular diagnostic tests do you use in your laboratory? (Select all that apply)
(Required.)
Reverse transcriptase quantitative polymerase chain reaction (rRT-qPCR)
Reverse transcription loop-mediated isothermal amplification (RT-LAMP)
Recombinase polymerase amplification (RPA)
CRISPR-based diagnostics
DNA/Genetic testing
Flow cytometry
Liquid biopsy
Mass Spectrometry
Next generation sequencing
Rapid antigen test
Rapid molecular test
None
Other (please specify)
*
8.
Which clinical areas are driving the most demand for molecular testing in your lab? (Select all that apply)
(Required.)
Infectious disease (non-COVID)
Oncology
Pharmacogenomics
Genetic/hereditary testing
Reproductive health
Transplant medicine
Neurology
Cardiology
Other (please specify)
*
9.
Does your lab participate in proficiency testing for molecular assays? If yes, through whom? (Select all that apply)
(Required.)
CAP
API
CDC
WSLH Proficiency Testing
My lab does not participate in proficiency testing for molecular assays
Other (please specify)
*
10.
Which of the following three molecular diagnostic test companies do you use the most? (Select three)
(Required.)
Abbott
Agilent Technologies
BD
Beckman Coulter
bioMérieux
Bio-Rad
Cepheid
DiaSorin
ELITech Group
Euroimmun/Revvity
GenMark
Hardy Diagnostics
Hologic
Illumina
LabCorp
Leica
Meridian Bioscience
Qiagen
Quest
QuidelOrtho
Roche
Seegene
Siemens
Thermo Fisher Scientific
We outsource all molecular testing
Other (please specify)
*
11.
How do you handle questionable results with molecular tests? (Select only one)
(Required.)
Repeat the test
Repeat the test with different employee/equipment/test
Verify all pre-analytical, analytical, and/or post-analytical steps are performed correctly
Send results to another lab for verification and second test
Other (please specify)
*
12.
What steps does your lab take to reduce the number of potential false positive test results? (Select top three)
(Required.)
Repeat the test with the same sample and new extractions
Repeat the test with another method and compare results
Verify all pre-analytic, analytic, post-analytic steps are performed correctly
Refer to quality assurance program guidance
Decontaminate work/test area per laboratory procedures
None
Other (please specify)
*
13.
Have you adopted or are you planning to adopt AI/ML tools for molecular diagnostics? (Select only one)
(Required.)
Yes, already using
Yes, planning to adopt
No, we are not currently using but plan to
No, we are not currently using and have no plans to
14.
If you would like to be contacted to contribute to this article or other future articles, please provide the following:
First Name
Last Name
Title
Company
Phone
Email